OA11452A - Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems. - Google Patents
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems. Download PDFInfo
- Publication number
- OA11452A OA11452A OA1200000225A OA1200000225A OA11452A OA 11452 A OA11452 A OA 11452A OA 1200000225 A OA1200000225 A OA 1200000225A OA 1200000225 A OA1200000225 A OA 1200000225A OA 11452 A OA11452 A OA 11452A
- Authority
- OA
- OAPI
- Prior art keywords
- formula
- phenyl
- compound
- group
- palladium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15161599P | 1999-08-31 | 1999-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11452A true OA11452A (en) | 2003-12-08 |
Family
ID=22539529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200000225A OA11452A (en) | 1999-08-31 | 2000-08-18 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems. |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6346624B1 (pt) |
| EP (1) | EP1081143A1 (pt) |
| JP (1) | JP2001106682A (pt) |
| KR (1) | KR20010050256A (pt) |
| CN (1) | CN1286250A (pt) |
| AP (1) | AP2000001910A0 (pt) |
| AU (1) | AU5360300A (pt) |
| BG (1) | BG104731A (pt) |
| BR (1) | BR0003945A (pt) |
| CA (1) | CA2317097A1 (pt) |
| CZ (1) | CZ20003158A3 (pt) |
| EA (1) | EA200000801A1 (pt) |
| EE (1) | EE200000512A (pt) |
| GT (1) | GT200000142A (pt) |
| HR (1) | HRP20000564A2 (pt) |
| HU (1) | HUP0003439A3 (pt) |
| ID (1) | ID27129A (pt) |
| IL (1) | IL138087A0 (pt) |
| IS (1) | IS5603A (pt) |
| MA (1) | MA26751A1 (pt) |
| NO (1) | NO20004313L (pt) |
| NZ (1) | NZ506632A (pt) |
| OA (1) | OA11452A (pt) |
| PA (1) | PA8499701A1 (pt) |
| PE (1) | PE20010520A1 (pt) |
| PL (1) | PL342281A1 (pt) |
| SG (1) | SG87146A1 (pt) |
| SK (1) | SK12872000A3 (pt) |
| SV (1) | SV2002000159A (pt) |
| TN (1) | TNSN00177A1 (pt) |
| TR (1) | TR200002529A2 (pt) |
| UY (1) | UY26314A1 (pt) |
| ZA (1) | ZA200004435B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669042B1 (en) * | 2002-09-30 | 2003-12-30 | Hewlett-Packard Development Company, L.P. | Integrated positioning and locking device |
| US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| US6063928A (en) * | 1994-10-18 | 2000-05-16 | Pfizer Inc | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| US6239285B1 (en) * | 1998-02-06 | 2001-05-29 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
-
2000
- 2000-06-29 US US09/607,011 patent/US6346624B1/en not_active Expired - Fee Related
- 2000-08-01 SG SG200004341A patent/SG87146A1/en unknown
- 2000-08-10 PA PA20008499701A patent/PA8499701A1/es unknown
- 2000-08-16 EP EP00307014A patent/EP1081143A1/en not_active Withdrawn
- 2000-08-18 OA OA1200000225A patent/OA11452A/en unknown
- 2000-08-24 AU AU53603/00A patent/AU5360300A/en not_active Abandoned
- 2000-08-24 IL IL13808700A patent/IL138087A0/xx unknown
- 2000-08-25 IS IS5603A patent/IS5603A/is unknown
- 2000-08-25 SK SK1287-2000A patent/SK12872000A3/sk unknown
- 2000-08-28 ZA ZA200004435A patent/ZA200004435B/xx unknown
- 2000-08-28 GT GT200000142A patent/GT200000142A/es unknown
- 2000-08-28 UY UY26314A patent/UY26314A1/es not_active Application Discontinuation
- 2000-08-28 ID IDP20000711A patent/ID27129A/id unknown
- 2000-08-29 PE PE2000000885A patent/PE20010520A1/es not_active Application Discontinuation
- 2000-08-29 CA CA002317097A patent/CA2317097A1/en not_active Abandoned
- 2000-08-29 JP JP2000259063A patent/JP2001106682A/ja active Pending
- 2000-08-29 BG BG104731A patent/BG104731A/xx unknown
- 2000-08-30 HR HR20000564A patent/HRP20000564A2/hr not_active Application Discontinuation
- 2000-08-30 EA EA200000801A patent/EA200000801A1/ru unknown
- 2000-08-30 MA MA26054A patent/MA26751A1/fr unknown
- 2000-08-30 KR KR1020000050608A patent/KR20010050256A/ko active IP Right Grant
- 2000-08-30 NO NO20004313A patent/NO20004313L/no not_active Application Discontinuation
- 2000-08-30 HU HU0003439A patent/HUP0003439A3/hu unknown
- 2000-08-30 CN CN00126408A patent/CN1286250A/zh active Pending
- 2000-08-30 TN TNTNSN00177A patent/TNSN00177A1/fr unknown
- 2000-08-30 CZ CZ20003158A patent/CZ20003158A3/cs unknown
- 2000-08-30 SV SV2000000159A patent/SV2002000159A/es unknown
- 2000-08-30 NZ NZ506632A patent/NZ506632A/en unknown
- 2000-08-31 PL PL00342281A patent/PL342281A1/xx not_active Application Discontinuation
- 2000-08-31 EE EEP200000512A patent/EE200000512A/xx unknown
- 2000-08-31 TR TR2000/02529A patent/TR200002529A2/xx unknown
- 2000-08-31 AP APAP/P/2000/001910A patent/AP2000001910A0/en unknown
- 2000-08-31 BR BR0003945-4A patent/BR0003945A/pt not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3882142A (en) | 1,2-Dialkyl-3,5-diphenyl pyrazolium salts | |
| CN110028489B (zh) | 一种减压法制备苯甲酰胺类化合物的方法 | |
| CN112390725B (zh) | 一种酰胺类化合物的制备方法 | |
| KR100720220B1 (ko) | 치환 아닐린 화합물의 제조방법 | |
| OA11452A (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems. | |
| NO165104B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
| CA1276017C (en) | Sulfenamide derivatives and their production | |
| US5808086A (en) | Process for preparing bis (2-hydroxyphenyl-3-benztriazole) methanes | |
| US6344563B1 (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | |
| US6239285B1 (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | |
| US3952010A (en) | Catalytic dehydrogenation process for the preparation of 3,5-disubstituted pyrazoles | |
| US4057546A (en) | 4-Amino-1,2,4-triazin-5-ones | |
| OA11451A (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems. | |
| EP0916656B1 (en) | A method for production of pyrrolidinone derivatives | |
| US5498725A (en) | Process for preparing 5-aminodihydropyrrole intermediate thereof and process for preparing said intermediate | |
| US4374281A (en) | Process for the manufacture of hydroquinone-monophenyl ethers | |
| CA1273345A (en) | Process for the production of 3-phenyl-4- cyanopyrroles | |
| US6562979B1 (en) | Process for the preparation of substituted benzisothiazole compounds | |
| GB2186571A (en) | Imidazol-1-yl-carboxylic acid ester derivatives, processes for preparing same and fungicidal compositions comprising the derivative as active component | |
| JPS6012341B2 (ja) | インダン誘導体の製造法 |